PROTEOME SCIENCES PLC (PRM) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen. Welcome to the PROTEOME SCIENCES PLC Interim Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Just please simply type in your question and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, we would like to submit the following poll, and I'm sure the company will be most grateful for your participation. And I'd now like to hand over to CEO, Doctor. Mariola Good morning. Good morning, and a very warm welcome to the presentation of PROTEOME SCIENCES Interim Results for the First Six Months of twenty twenty two. My name is Mario Lazuengan, and I'm the CEO of PROTEOME SCIENCES. Cannot spare you the disclaimer for just a second, which basically points to the fact that we will be making forward looking statements in this presentation, and this this presentation is not based as an investment advice. So for those of you not that familiar with PROTEOME SCIENCES, just a short introduction what we are doing and who we are. We are a leading provider of contract research services, and this is all around PROTEOME biomarkers. Now our business consists of basically two main business areas. One is TMT, tender mass tax, and the other one is our service business around this set biomarkers. So what are TMTs? Tandem Mass Tags, these are molecules that are used to lay proteins. And by labeling them, mass spectrometry can pick them up more easily and can analyze them, basically. Thi...